277 related articles for article (PubMed ID: 29203479)
21. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
22. Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.
Ok HS; Lee HS; Park MJ; Kim KH; Kim BK; Wi YM; Kim JM
Korean J Intern Med; 2013 Nov; 28(6):678-86. PubMed ID: 24307843
[TBL] [Abstract][Full Text] [Related]
23. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
24. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
[TBL] [Abstract][Full Text] [Related]
25. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
26. Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study.
Cabanilla MG; Bernauer ML; Atallah LM; Briski MJ; Koury J; Thompson CM; Rodriguez CN; Jakeman B; Byrd TF
PLoS One; 2024; 19(5):e0304103. PubMed ID: 38768130
[TBL] [Abstract][Full Text] [Related]
27. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
Jones D; Elshaboury RH; Munson E; Dilworth TJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
[No Abstract] [Full Text] [Related]
28. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
29. [Staphylococcus aureus bacteremia - a distinct entity].
Weis S; Kaasch AJ; Rieg S; Löffler B; Hagel S; Forstner C; Brunkhorst FM; Pletz MW
Dtsch Med Wochenschr; 2015 Jun; 140(13):982-9. PubMed ID: 26115133
[TBL] [Abstract][Full Text] [Related]
30. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of bacteremia caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital.
Yamada K; Yanagihara K; Hara Y; Araki N; Harada Y; Morinaga Y; Matsuda J; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Kohno S; Kamihira S
Tohoku J Exp Med; 2011 May; 224(1):61-7. PubMed ID: 21551983
[TBL] [Abstract][Full Text] [Related]
32. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
Melzer M; Eykyn SJ; Gransden WR; Chinn S
Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
[TBL] [Abstract][Full Text] [Related]
33. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
BMC Infect Dis; 2016 Jul; 16():331. PubMed ID: 27418274
[TBL] [Abstract][Full Text] [Related]
34. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
[TBL] [Abstract][Full Text] [Related]
35. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
36. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
[TBL] [Abstract][Full Text] [Related]
37. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
[TBL] [Abstract][Full Text] [Related]
38. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
[TBL] [Abstract][Full Text] [Related]
39. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
